Halozyme Therapeutics Inc (HALO)

[jamtomorrow2]

Interesting news from Shire's Annual Report today. They say the conversion rate from Gammagard (or whatever they call it now) to HyQ is quite high. Strange as that's not really bourne out yet in HALO's royalty figures - probably because it's only been launched in minor markets. Also they will know the results of their Phase 3 SQ Cinryse trial (without Enhanze) in 2017. Be interesting to see whether it's an abject failure like we all hope and they have to come creeping back to HALO. Also Shire is being sued by the authorities for making endless pointless objections to stop others coming up with a generic of Cinryse (it's not patented). As I've been saying for years I couldn't understand why HALO didn't pursue this option once Viropharma kicked us into touch. I suppose we couldn't due to some contractual condition, which of course is something that could be a problem for HALO. For instance for all we know the Phase 1 SQ Humira trial could have been a big success but now that ABbvie have kicked us into touch we probably can't work on Humira for anyone else or even ourselves.